MedTrace Logo

An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries

NCT02247713 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 520

Last updated 2014-09-25

No results posted yet for this study

Summary

A part retrospective, part prospective cohort study to assess the difference in 2-year overall survival in patients with stage III NSCLC receiving chemoradiotherapy with curative intent in low and middle income countries before and after a training intervention on the use of PET/CT for radiotherapy treatment planning.

Conditions

  • Non Small Cell Lung Cancer Stage III

Sponsors & Collaborators

  • International Atomic Energy Agency

    collaborator OTHER_GOV

  • The Netherlands Cancer Institute

    lead OTHER

Principal Investigators

  • Wouter V Vogel, MD · Antoni van Leeuwenhoek - Netherlands Cancer Institute

  • Gerard G Hanna, MD · Centre for Cancer Research and Cell Biology, Queen's University Belfast

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-12-31
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02247713 on ClinicalTrials.gov